Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 32 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

8 trials in Phase 3/4

Results Transparency

0%

0 of 20 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
15(62.5%)
Phase 4
8(33.3%)
Phase 2
1(4.2%)
24Total
N/A(15)
Phase 4(8)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (32)

Showing 20 of 32 trials
NCT07379983Phase 4Completed

Evaluating the Effectiveness of Print Based Environmental Health Intervention Education Among School Going Adolescents of Karachi, A Quasi Study

Role: lead

NCT06606886Phase 4Completed

Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia

Role: lead

NCT06759922Phase 4Completed

Glimepiride, Empagliflozin, and Sitagliptin With Metformin for Type 2 Diabetes

Role: lead

NCT07385781Not Yet Recruiting

Psychosomatic Symptoms in Patients With Myofascial Pain and Temporomandibular Joint Dysfunction

Role: lead

NCT07452913Phase 4Enrolling By Invitation

Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes

Role: lead

NCT07375082Active Not Recruiting

Rehabilitation Approaches Used in Total Knee Replacement

Role: lead

NCT07354529Not ApplicableActive Not Recruiting

Date Fruit Benefits to Treat Morning Sickness in First Trimester of Pregnancy

Role: lead

NCT07338955Recruiting

Validating and Assessing Reliability

Role: lead

NCT06929754Not ApplicableCompleted

To Compare the Effects of Lip Bumper Appliance in Rate of Lower Incisor Alignment After First Premolar Extractions

Role: lead

NCT07255820Phase 4Not Yet Recruiting

Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol

Role: lead

NCT07247656Phase 4Completed

The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Body Weight in Type 2 Diabetic Patients .

Role: lead

NCT07210762Not ApplicableRecruiting

Gingival Cleft Development at Two Time Points of Canine Retraction

Role: lead

NCT06602765Not ApplicableActive Not Recruiting

Comparative Analysis of Interventions for Prevention of Dental Caries in School Children

Role: lead

NCT05149235Not ApplicableCompleted

Gaming Technology and Cardiac Rehabilitation

Role: lead

NCT06856369Phase 4Active Not Recruiting

Clinical Efficacy of 1% Metformin and Alendronate Gel in Adjunct to Fibrin in Chronic Periodontitis

Role: lead

NCT06842108Recruiting

Relationship Between Hemodynamic Changes and Cardiopulmonary Fitness in Type 2 Diabetes Mellitus Patients

Role: lead

NCT06829511Not Yet Recruiting

BARRIERS TOWARDS PHYSICAL ACTIVITY

Role: lead

NCT06808659Not ApplicableCompleted

Effects of Neural Mobilization and Stretching in Piriformis Syndrome

Role: lead

NCT05578963Completed

Correlation Between Palmaris Longus Muscle and Carpel Tunnel Syndrome

Role: lead

NCT06772012Not ApplicableCompleted

Effectiveness of Low-Level Laser Therapy (LLLT) Versus Orofacial Physical Therapy for Temporomandibular Dysfunction. a Randomized Controlled Trial

Role: lead